Bank of America’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,956
| Closed | -$146K | – | 7102 |
|
|
2020
Q4 | $146K | Buy |
7,956
+4,522
| +132% | +$83K | ﹤0.01% | 5068 |
|
|
2020
Q3 | $63K | Sell |
3,434
-2,081
| -38% | -$38.2K | ﹤0.01% | 5281 |
|
|
2020
Q2 | $83K | Buy |
5,515
+2,367
| +75% | +$35.6K | ﹤0.01% | 5202 |
|
|
2020
Q1 | $50K | Sell |
3,148
-1,783
| -36% | -$28.3K | ﹤0.01% | 5278 |
|
|
2019
Q4 | $80K | Sell |
4,931
-482
| -9% | -$7.82K | ﹤0.01% | 5275 |
|
|
2019
Q3 | $80K | Buy |
5,413
+778
| +17% | +$11.5K | ﹤0.01% | 5327 |
|
|
2019
Q2 | $77K | Buy |
4,635
+1,995
| +76% | +$33.1K | ﹤0.01% | 5351 |
|
|
2019
Q1 | $46K | Sell |
2,640
-7,808
| -75% | -$136K | ﹤0.01% | 5469 |
|
|
2018
Q4 | $185K | Buy |
10,448
+7,054
| +208% | +$125K | ﹤0.01% | 4852 |
|
|
2018
Q3 | $61K | Buy |
3,394
+1,542
| +83% | +$27.7K | ﹤0.01% | 5397 |
|
|
2018
Q2 | $37K | Sell |
1,852
-1,501
| -45% | -$30K | ﹤0.01% | 5560 |
|
|
2018
Q1 | $59K | Buy |
+3,353
| New | +$59K | ﹤0.01% | 5241 |
|
|
2017
Q3 | – | Sell |
-3,206
| Closed | -$28K | – | 6411 |
|
|
2017
Q2 | $28K | Buy |
3,206
+1,052
| +49% | +$9.19K | ﹤0.01% | 5351 |
|
|
2017
Q1 | $25K | Buy |
2,154
+384
| +22% | +$4.46K | ﹤0.01% | 5486 |
|
|
2016
Q4 | $23K | Buy |
1,770
+1,106
| +167% | +$14.4K | ﹤0.01% | 5521 |
|
|
2016
Q3 | $9K | Buy |
664
+335
| +102% | +$4.54K | ﹤0.01% | 5662 |
|
|
2016
Q2 | $4K | Buy |
+329
| New | +$4K | ﹤0.01% | 5937 |
|
|
2016
Q1 | – | Sell |
-238
| Closed | -$5K | – | 6337 |
|
|
2015
Q4 | $5K | Buy |
238
+190
| +396% | +$3.99K | ﹤0.01% | 5873 |
|
|
2015
Q3 | $1K | Sell |
48
-224
| -82% | -$4.67K | ﹤0.01% | 6013 |
|
|
2015
Q2 | $10K | Buy |
+272
| New | +$10K | ﹤0.01% | 5560 |
|
|
2014
Q4 | – | Sell |
-502
| Closed | -$11K | – | 6128 |
|
|
2014
Q3 | $11K | Buy |
+502
| New | +$11K | ﹤0.01% | 5432 |
|